SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

Two ANS standards open for public comment

May 11, 2026, 3:09PMNuclear News

The American Nuclear Society recently opened two draft standards for public review. Previously, announcements of public review opportunities for ANS standards have been published exclusively...

NRC approves St. Lucie SLRs

May 1, 2026, 9:26AMNuclear News

The Nuclear Regulatory Commission has approved subsequent license renewals for St. Lucie Units 1 and 2, extending the operating licenses for the pressurized water reactors by another 20...